It's been hard not to get focused on the saga on Wall Street. But there is other news going on in the industry.
On Friday, Walgreen launched a surprise counteroffer for Longs Drugs, which CVS had previously agreed to acquire.
Now, Longs has rejected the offer from Walgreen and continues to recommend the CVS bid to its shareholders.
Sponsored Introduction Continue on to (or wait seconds) ×